Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The triglyceride synthesis enzyme complex refers to the group of enzymes responsible for catalyzing the biosynthesis of triglycerides (also called triacylglycerols, TAGs) from glycerol and fatty acids. This process is essential for energy storage in animals and humans, as triglycerides are the main constituents of body fat and a major form of energy reserve. Key enzymes involved include Glycerol-3-phosphate acyltransferase (GPAT), Acylglycerophosphate acyltransferase (AGPAT), Phosphatidic acid phosphatases (PAPs or lipins), and Diacylglycerol O-acyltransferases (DGAT1 and DGAT2).
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Triglyceride Synthesis Enzyme Complex (None).